DRTS
Alpha Tau Medical·NASDAQ
--
--(--)
--
--(--)
0.70 / 10
Underperform
Fundamental assessment is selective due to concerning quality (0.7/10). Key red flags include negative net profit margin (-2976.84%) and net income-to-revenue (-2168.27%), indicating deep operational losses. However, the net profit attributable to parent company shareholders ratio is a strong 100%, and Cash-UP shows a moderate positive signal. Overall, the company's financial health is fragile, warranting a defensive stance.
Analysis Checks(2/10)
Revenue-MV
Value-0.26
Score0/3
Weight18.72%
1M Return-4.37%
Value-0.26
Score0/3
Weight18.72%
1M Return-4.37%
Net cash flow from operating activities / Operating revenue (%)
Value-1515.96
Score0/3
Weight24.14%
1M Return-6.72%
Value-1515.96
Score0/3
Weight24.14%
1M Return-6.72%
Net profit margin (%)
Value-2976.84
Score0/3
Weight25.40%
1M Return-7.14%
Value-2976.84
Score0/3
Weight25.40%
1M Return-7.14%
Cash-UP
Value-0.05
Score2/3
Weight-14.23%
1M Return2.84%
Value-0.05
Score2/3
Weight-14.23%
1M Return2.84%
Net profit / Total operating revenue (%)
Value-2168.27
Score0/3
Weight25.09%
1M Return-7.04%
Value-2168.27
Score0/3
Weight25.09%
1M Return-7.04%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight6.14%
1M Return-1.45%
Value100.00
Score2/3
Weight6.14%
1M Return-1.45%
Net income-Revenue
Value-0.15
Score1/3
Weight3.13%
1M Return-0.68%
Value-0.15
Score1/3
Weight3.13%
1M Return-0.68%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.53%
1M Return-0.98%
Value1.78
Score1/3
Weight4.53%
1M Return-0.98%
Asset-MV
Value-0.51
Score1/3
Weight1.54%
1M Return-0.30%
Value-0.51
Score1/3
Weight1.54%
1M Return-0.30%
Cash-MV
Value-0.07
Score0/3
Weight5.54%
1M Return-1.26%
Value-0.07
Score0/3
Weight5.54%
1M Return-1.26%
Revenue-MV
Value-0.26
Score0/3
Weight18.72%
1M Return-4.37%
Value-0.26
Score0/3
Weight18.72%
1M Return-4.37%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight6.14%
1M Return-1.45%
Value100.00
Score2/3
Weight6.14%
1M Return-1.45%
Net cash flow from operating activities / Operating revenue (%)
Value-1515.96
Score0/3
Weight24.14%
1M Return-6.72%
Value-1515.96
Score0/3
Weight24.14%
1M Return-6.72%
Net income-Revenue
Value-0.15
Score1/3
Weight3.13%
1M Return-0.68%
Value-0.15
Score1/3
Weight3.13%
1M Return-0.68%
Net profit margin (%)
Value-2976.84
Score0/3
Weight25.40%
1M Return-7.14%
Value-2976.84
Score0/3
Weight25.40%
1M Return-7.14%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.53%
1M Return-0.98%
Value1.78
Score1/3
Weight4.53%
1M Return-0.98%
Cash-UP
Value-0.05
Score2/3
Weight-14.23%
1M Return2.84%
Value-0.05
Score2/3
Weight-14.23%
1M Return2.84%
Asset-MV
Value-0.51
Score1/3
Weight1.54%
1M Return-0.30%
Value-0.51
Score1/3
Weight1.54%
1M Return-0.30%
Net profit / Total operating revenue (%)
Value-2168.27
Score0/3
Weight25.09%
1M Return-7.04%
Value-2168.27
Score0/3
Weight25.09%
1M Return-7.04%
Cash-MV
Value-0.07
Score0/3
Weight5.54%
1M Return-1.26%
Value-0.07
Score0/3
Weight5.54%
1M Return-1.26%
Is DRTS undervalued or overvalued?
- DRTS scores 0.70/10 on fundamentals and holds a Premium valuation at present. Backed by its -43.48% ROE, 0.00% net margin, -15.17 P/E ratio, 7.81 P/B ratio, and -20.93% earnings growth, these metrics solidify its Underperform investment rating.
